nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—ABCB1—Methylprednisolone—psoriatic arthritis	0.197	0.279	CbGbCtD
Scopolamine—ABCB1—Betamethasone—psoriatic arthritis	0.128	0.182	CbGbCtD
Scopolamine—ABCB1—Prednisolone—psoriatic arthritis	0.126	0.179	CbGbCtD
Scopolamine—ABCB1—Prednisone—psoriatic arthritis	0.119	0.169	CbGbCtD
Scopolamine—ABCB1—Dexamethasone—psoriatic arthritis	0.0743	0.106	CbGbCtD
Scopolamine—ABCB1—Methotrexate—psoriatic arthritis	0.0597	0.0849	CbGbCtD
Scopolamine—Dysphagia—Auranofin—psoriatic arthritis	0.00682	0.023	CcSEcCtD
Scopolamine—Drug withdrawal syndrome—Methylprednisolone—psoriatic arthritis	0.00648	0.0219	CcSEcCtD
Scopolamine—Conjunctivitis—Auranofin—psoriatic arthritis	0.00591	0.0199	CcSEcCtD
Scopolamine—Drug withdrawal syndrome—Dexamethasone—psoriatic arthritis	0.00589	0.0199	CcSEcCtD
Scopolamine—Drug withdrawal syndrome—Betamethasone—psoriatic arthritis	0.00589	0.0199	CcSEcCtD
Scopolamine—Visual impairment—Auranofin—psoriatic arthritis	0.00526	0.0177	CcSEcCtD
Scopolamine—Drug withdrawal syndrome—Prednisone—psoriatic arthritis	0.00513	0.0173	CcSEcCtD
Scopolamine—Eye disorder—Auranofin—psoriatic arthritis	0.0051	0.0172	CcSEcCtD
Scopolamine—Mydriasis—Prednisolone—psoriatic arthritis	0.00434	0.0147	CcSEcCtD
Scopolamine—Constipation—Auranofin—psoriatic arthritis	0.00331	0.0112	CcSEcCtD
Scopolamine—Abdominal pain—Auranofin—psoriatic arthritis	0.00306	0.0103	CcSEcCtD
Scopolamine—Pruritus—Auranofin—psoriatic arthritis	0.00274	0.00926	CcSEcCtD
Scopolamine—Dry eye—Dexamethasone—psoriatic arthritis	0.00267	0.00901	CcSEcCtD
Scopolamine—Dry eye—Betamethasone—psoriatic arthritis	0.00267	0.00901	CcSEcCtD
Scopolamine—Vomiting—Auranofin—psoriatic arthritis	0.00246	0.00832	CcSEcCtD
Scopolamine—Amnesia—Methylprednisolone—psoriatic arthritis	0.00246	0.00829	CcSEcCtD
Scopolamine—Speech disorder—Methotrexate—psoriatic arthritis	0.00245	0.00826	CcSEcCtD
Scopolamine—Rash—Auranofin—psoriatic arthritis	0.00244	0.00825	CcSEcCtD
Scopolamine—Dermatitis—Auranofin—psoriatic arthritis	0.00244	0.00824	CcSEcCtD
Scopolamine—Dry skin—Prednisolone—psoriatic arthritis	0.00231	0.00778	CcSEcCtD
Scopolamine—Nausea—Auranofin—psoriatic arthritis	0.0023	0.00777	CcSEcCtD
Scopolamine—Psychotic disorder—Methylprednisolone—psoriatic arthritis	0.00225	0.00761	CcSEcCtD
Scopolamine—Muscular weakness—Prednisolone—psoriatic arthritis	0.00222	0.00749	CcSEcCtD
Scopolamine—Irritability—Methylprednisolone—psoriatic arthritis	0.0022	0.00743	CcSEcCtD
Scopolamine—Psychotic disorder—Dexamethasone—psoriatic arthritis	0.00205	0.00692	CcSEcCtD
Scopolamine—Psychotic disorder—Betamethasone—psoriatic arthritis	0.00205	0.00692	CcSEcCtD
Scopolamine—Muscular weakness—Triamcinolone—psoriatic arthritis	0.00204	0.00688	CcSEcCtD
Scopolamine—Muscular weakness—Methylprednisolone—psoriatic arthritis	0.00204	0.00687	CcSEcCtD
Scopolamine—Depressed level of consciousness—Methotrexate—psoriatic arthritis	0.00203	0.00686	CcSEcCtD
Scopolamine—Irritability—Dexamethasone—psoriatic arthritis	0.002	0.00676	CcSEcCtD
Scopolamine—Irritability—Betamethasone—psoriatic arthritis	0.002	0.00676	CcSEcCtD
Scopolamine—Amnesia—Prednisone—psoriatic arthritis	0.00195	0.00656	CcSEcCtD
Scopolamine—Dry skin—Dexamethasone—psoriatic arthritis	0.00192	0.00649	CcSEcCtD
Scopolamine—Dry skin—Betamethasone—psoriatic arthritis	0.00192	0.00649	CcSEcCtD
Scopolamine—Conjunctivitis—Prednisolone—psoriatic arthritis	0.00188	0.00636	CcSEcCtD
Scopolamine—Muscular weakness—Betamethasone—psoriatic arthritis	0.00185	0.00625	CcSEcCtD
Scopolamine—Muscular weakness—Dexamethasone—psoriatic arthritis	0.00185	0.00625	CcSEcCtD
Scopolamine—Psychotic disorder—Prednisone—psoriatic arthritis	0.00178	0.00602	CcSEcCtD
Scopolamine—Bradycardia—Prednisolone—psoriatic arthritis	0.00177	0.00598	CcSEcCtD
Scopolamine—Irritability—Prednisone—psoriatic arthritis	0.00174	0.00589	CcSEcCtD
Scopolamine—Conjunctivitis—Triamcinolone—psoriatic arthritis	0.00173	0.00585	CcSEcCtD
Scopolamine—Sweating—Methylprednisolone—psoriatic arthritis	0.0017	0.00575	CcSEcCtD
Scopolamine—Visual impairment—Prednisolone—psoriatic arthritis	0.00168	0.00566	CcSEcCtD
Scopolamine—Dry skin—Prednisone—psoriatic arthritis	0.00168	0.00565	CcSEcCtD
Scopolamine—Bradycardia—Triamcinolone—psoriatic arthritis	0.00163	0.0055	CcSEcCtD
Scopolamine—Bradycardia—Methylprednisolone—psoriatic arthritis	0.00163	0.00548	CcSEcCtD
Scopolamine—Muscular weakness—Prednisone—psoriatic arthritis	0.00161	0.00544	CcSEcCtD
Scopolamine—Hallucination—Methylprednisolone—psoriatic arthritis	0.00159	0.00536	CcSEcCtD
Scopolamine—Pharyngitis—Triamcinolone—psoriatic arthritis	0.00159	0.00536	CcSEcCtD
Scopolamine—Conjunctivitis—Betamethasone—psoriatic arthritis	0.00157	0.00531	CcSEcCtD
Scopolamine—Conjunctivitis—Dexamethasone—psoriatic arthritis	0.00157	0.00531	CcSEcCtD
Scopolamine—Arrhythmia—Prednisolone—psoriatic arthritis	0.00155	0.00525	CcSEcCtD
Scopolamine—Visual impairment—Methylprednisolone—psoriatic arthritis	0.00154	0.00519	CcSEcCtD
Scopolamine—Erythema—Prednisolone—psoriatic arthritis	0.00151	0.00511	CcSEcCtD
Scopolamine—Eye disorder—Methylprednisolone—psoriatic arthritis	0.00149	0.00503	CcSEcCtD
Scopolamine—Bradycardia—Dexamethasone—psoriatic arthritis	0.00148	0.00499	CcSEcCtD
Scopolamine—Bradycardia—Betamethasone—psoriatic arthritis	0.00148	0.00499	CcSEcCtD
Scopolamine—Irritability—Methotrexate—psoriatic arthritis	0.00146	0.00492	CcSEcCtD
Scopolamine—Hallucination—Dexamethasone—psoriatic arthritis	0.00144	0.00487	CcSEcCtD
Scopolamine—Hallucination—Betamethasone—psoriatic arthritis	0.00144	0.00487	CcSEcCtD
Scopolamine—Arrhythmia—Triamcinolone—psoriatic arthritis	0.00143	0.00482	CcSEcCtD
Scopolamine—Vision blurred—Prednisolone—psoriatic arthritis	0.00143	0.00482	CcSEcCtD
Scopolamine—Arrhythmia—Methylprednisolone—psoriatic arthritis	0.00143	0.00481	CcSEcCtD
Scopolamine—Visual impairment—Betamethasone—psoriatic arthritis	0.0014	0.00472	CcSEcCtD
Scopolamine—Visual impairment—Dexamethasone—psoriatic arthritis	0.0014	0.00472	CcSEcCtD
Scopolamine—Mental disorder—Methylprednisolone—psoriatic arthritis	0.0014	0.00472	CcSEcCtD
Scopolamine—Erythema—Triamcinolone—psoriatic arthritis	0.00139	0.0047	CcSEcCtD
Scopolamine—Erythema—Methylprednisolone—psoriatic arthritis	0.00139	0.00469	CcSEcCtD
Scopolamine—Vertigo—Prednisolone—psoriatic arthritis	0.00136	0.00459	CcSEcCtD
Scopolamine—Eye disorder—Dexamethasone—psoriatic arthritis	0.00136	0.00458	CcSEcCtD
Scopolamine—Eye disorder—Betamethasone—psoriatic arthritis	0.00136	0.00458	CcSEcCtD
Scopolamine—Arrhythmia—Dexamethasone—psoriatic arthritis	0.0013	0.00438	CcSEcCtD
Scopolamine—Arrhythmia—Betamethasone—psoriatic arthritis	0.0013	0.00438	CcSEcCtD
Scopolamine—Bradycardia—Prednisone—psoriatic arthritis	0.00129	0.00434	CcSEcCtD
Scopolamine—Erythema—Dexamethasone—psoriatic arthritis	0.00126	0.00427	CcSEcCtD
Scopolamine—Erythema—Betamethasone—psoriatic arthritis	0.00126	0.00427	CcSEcCtD
Scopolamine—Hallucination—Prednisone—psoriatic arthritis	0.00126	0.00425	CcSEcCtD
Scopolamine—Vertigo—Triamcinolone—psoriatic arthritis	0.00125	0.00422	CcSEcCtD
Scopolamine—Vertigo—Methylprednisolone—psoriatic arthritis	0.00125	0.00421	CcSEcCtD
Scopolamine—Oedema—Prednisolone—psoriatic arthritis	0.00124	0.00417	CcSEcCtD
Scopolamine—Dysuria—Methotrexate—psoriatic arthritis	0.00123	0.00417	CcSEcCtD
Scopolamine—Tachycardia—Prednisolone—psoriatic arthritis	0.00121	0.00407	CcSEcCtD
Scopolamine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00119	0.00403	CcSEcCtD
Scopolamine—Eye disorder—Prednisone—psoriatic arthritis	0.00118	0.00399	CcSEcCtD
Scopolamine—Drowsiness—Methotrexate—psoriatic arthritis	0.00118	0.00397	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00117	0.00397	CcSEcCtD
Scopolamine—Flushing—Prednisone—psoriatic arthritis	0.00117	0.00396	CcSEcCtD
Scopolamine—Dry mouth—Triamcinolone—psoriatic arthritis	0.00116	0.00391	CcSEcCtD
Scopolamine—Conjunctivitis—Methotrexate—psoriatic arthritis	0.00114	0.00386	CcSEcCtD
Scopolamine—Confusional state—Methylprednisolone—psoriatic arthritis	0.00114	0.00386	CcSEcCtD
Scopolamine—Oedema—Triamcinolone—psoriatic arthritis	0.00114	0.00384	CcSEcCtD
Scopolamine—Vertigo—Dexamethasone—psoriatic arthritis	0.00114	0.00383	CcSEcCtD
Scopolamine—Vertigo—Betamethasone—psoriatic arthritis	0.00114	0.00383	CcSEcCtD
Scopolamine—Arrhythmia—Prednisone—psoriatic arthritis	0.00113	0.00381	CcSEcCtD
Scopolamine—Sweating—Methotrexate—psoriatic arthritis	0.00113	0.00381	CcSEcCtD
Scopolamine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00111	0.00375	CcSEcCtD
Scopolamine—Tachycardia—Triamcinolone—psoriatic arthritis	0.00111	0.00374	CcSEcCtD
Scopolamine—Mental disorder—Prednisone—psoriatic arthritis	0.00111	0.00374	CcSEcCtD
Scopolamine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00111	0.00374	CcSEcCtD
Scopolamine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.0011	0.00372	CcSEcCtD
Scopolamine—Erythema—Prednisone—psoriatic arthritis	0.0011	0.00371	CcSEcCtD
Scopolamine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.0011	0.00371	CcSEcCtD
Scopolamine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.0011	0.0037	CcSEcCtD
Scopolamine—Hypotension—Methylprednisolone—psoriatic arthritis	0.00106	0.00358	CcSEcCtD
Scopolamine—Pain—Prednisolone—psoriatic arthritis	0.00106	0.00357	CcSEcCtD
Scopolamine—Pharyngitis—Methotrexate—psoriatic arthritis	0.00105	0.00354	CcSEcCtD
Scopolamine—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00104	0.00352	CcSEcCtD
Scopolamine—Vision blurred—Prednisone—psoriatic arthritis	0.00104	0.0035	CcSEcCtD
Scopolamine—Urethral disorder—Methotrexate—psoriatic arthritis	0.00104	0.0035	CcSEcCtD
Scopolamine—Oedema—Dexamethasone—psoriatic arthritis	0.00103	0.00348	CcSEcCtD
Scopolamine—Oedema—Betamethasone—psoriatic arthritis	0.00103	0.00348	CcSEcCtD
Scopolamine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00102	0.00344	CcSEcCtD
Scopolamine—Visual impairment—Methotrexate—psoriatic arthritis	0.00102	0.00344	CcSEcCtD
Scopolamine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00101	0.00341	CcSEcCtD
Scopolamine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00101	0.00341	CcSEcCtD
Scopolamine—Agitation—Prednisone—psoriatic arthritis	0.00101	0.00341	CcSEcCtD
Scopolamine—Tachycardia—Betamethasone—psoriatic arthritis	0.00101	0.0034	CcSEcCtD
Scopolamine—Tachycardia—Dexamethasone—psoriatic arthritis	0.00101	0.0034	CcSEcCtD
Scopolamine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000997	0.00337	CcSEcCtD
Scopolamine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000997	0.00337	CcSEcCtD
Scopolamine—Vertigo—Prednisone—psoriatic arthritis	0.000989	0.00334	CcSEcCtD
Scopolamine—Eye disorder—Methotrexate—psoriatic arthritis	0.000987	0.00333	CcSEcCtD
Scopolamine—Fatigue—Triamcinolone—psoriatic arthritis	0.00098	0.00331	CcSEcCtD
Scopolamine—Fatigue—Methylprednisolone—psoriatic arthritis	0.000978	0.0033	CcSEcCtD
Scopolamine—Pain—Triamcinolone—psoriatic arthritis	0.000972	0.00328	CcSEcCtD
Scopolamine—Hypotension—Dexamethasone—psoriatic arthritis	0.000964	0.00325	CcSEcCtD
Scopolamine—Hypotension—Betamethasone—psoriatic arthritis	0.000964	0.00325	CcSEcCtD
Scopolamine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000937	0.00316	CcSEcCtD
Scopolamine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000935	0.00315	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00093	0.00314	CcSEcCtD
Scopolamine—Mental disorder—Methotrexate—psoriatic arthritis	0.000926	0.00312	CcSEcCtD
Scopolamine—Erythema—Methotrexate—psoriatic arthritis	0.00092	0.0031	CcSEcCtD
Scopolamine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000899	0.00303	CcSEcCtD
Scopolamine—Oedema—Prednisone—psoriatic arthritis	0.000898	0.00303	CcSEcCtD
Scopolamine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000897	0.00303	CcSEcCtD
Scopolamine—Fatigue—Dexamethasone—psoriatic arthritis	0.000889	0.003	CcSEcCtD
Scopolamine—Fatigue—Betamethasone—psoriatic arthritis	0.000889	0.003	CcSEcCtD
Scopolamine—Pain—Dexamethasone—psoriatic arthritis	0.000882	0.00298	CcSEcCtD
Scopolamine—Pain—Betamethasone—psoriatic arthritis	0.000882	0.00298	CcSEcCtD
Scopolamine—Nervous system disorder—Prednisone—psoriatic arthritis	0.000881	0.00297	CcSEcCtD
Scopolamine—Tachycardia—Prednisone—psoriatic arthritis	0.000877	0.00296	CcSEcCtD
Scopolamine—Skin disorder—Prednisone—psoriatic arthritis	0.000872	0.00294	CcSEcCtD
Scopolamine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000868	0.00293	CcSEcCtD
Scopolamine—Vision blurred—Methotrexate—psoriatic arthritis	0.000867	0.00293	CcSEcCtD
Scopolamine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00085	0.00287	CcSEcCtD
Scopolamine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00085	0.00287	CcSEcCtD
Scopolamine—Vertigo—Methotrexate—psoriatic arthritis	0.000826	0.00279	CcSEcCtD
Scopolamine—Dizziness—Prednisolone—psoriatic arthritis	0.000817	0.00276	CcSEcCtD
Scopolamine—Asthenia—Triamcinolone—psoriatic arthritis	0.000816	0.00275	CcSEcCtD
Scopolamine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000815	0.00275	CcSEcCtD
Scopolamine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000815	0.00275	CcSEcCtD
Scopolamine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000815	0.00275	CcSEcCtD
Scopolamine—Body temperature increased—Betamethasone—psoriatic arthritis	0.000815	0.00275	CcSEcCtD
Scopolamine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000814	0.00275	CcSEcCtD
Scopolamine—Pruritus—Triamcinolone—psoriatic arthritis	0.000804	0.00271	CcSEcCtD
Scopolamine—Pruritus—Methylprednisolone—psoriatic arthritis	0.000802	0.00271	CcSEcCtD
Scopolamine—Rash—Prednisolone—psoriatic arthritis	0.000779	0.00263	CcSEcCtD
Scopolamine—Dermatitis—Prednisolone—psoriatic arthritis	0.000779	0.00263	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000778	0.00262	CcSEcCtD
Scopolamine—Fatigue—Prednisone—psoriatic arthritis	0.000774	0.00261	CcSEcCtD
Scopolamine—Headache—Prednisolone—psoriatic arthritis	0.000774	0.00261	CcSEcCtD
Scopolamine—Constipation—Prednisone—psoriatic arthritis	0.000768	0.00259	CcSEcCtD
Scopolamine—Confusional state—Methotrexate—psoriatic arthritis	0.000757	0.00255	CcSEcCtD
Scopolamine—Dizziness—Triamcinolone—psoriatic arthritis	0.000752	0.00254	CcSEcCtD
Scopolamine—Dizziness—Methylprednisolone—psoriatic arthritis	0.00075	0.00253	CcSEcCtD
Scopolamine—Feeling abnormal—Prednisone—psoriatic arthritis	0.00074	0.0025	CcSEcCtD
Scopolamine—Asthenia—Betamethasone—psoriatic arthritis	0.00074	0.0025	CcSEcCtD
Scopolamine—Asthenia—Dexamethasone—psoriatic arthritis	0.00074	0.0025	CcSEcCtD
Scopolamine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000736	0.00248	CcSEcCtD
Scopolamine—Nausea—Prednisolone—psoriatic arthritis	0.000734	0.00248	CcSEcCtD
Scopolamine—Pruritus—Betamethasone—psoriatic arthritis	0.00073	0.00246	CcSEcCtD
Scopolamine—Pruritus—Dexamethasone—psoriatic arthritis	0.00073	0.00246	CcSEcCtD
Scopolamine—Skin disorder—Methotrexate—psoriatic arthritis	0.000729	0.00246	CcSEcCtD
Scopolamine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000726	0.00245	CcSEcCtD
Scopolamine—Vomiting—Triamcinolone—psoriatic arthritis	0.000723	0.00244	CcSEcCtD
Scopolamine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000721	0.00243	CcSEcCtD
Scopolamine—Rash—Triamcinolone—psoriatic arthritis	0.000717	0.00242	CcSEcCtD
Scopolamine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000716	0.00242	CcSEcCtD
Scopolamine—Rash—Methylprednisolone—psoriatic arthritis	0.000715	0.00241	CcSEcCtD
Scopolamine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000714	0.00241	CcSEcCtD
Scopolamine—Headache—Triamcinolone—psoriatic arthritis	0.000712	0.0024	CcSEcCtD
Scopolamine—Headache—Methylprednisolone—psoriatic arthritis	0.00071	0.0024	CcSEcCtD
Scopolamine—Body temperature increased—Prednisone—psoriatic arthritis	0.00071	0.0024	CcSEcCtD
Scopolamine—Abdominal pain—Prednisone—psoriatic arthritis	0.00071	0.0024	CcSEcCtD
Scopolamine—Hypotension—Methotrexate—psoriatic arthritis	0.000701	0.00237	CcSEcCtD
Scopolamine—Dizziness—Dexamethasone—psoriatic arthritis	0.000682	0.0023	CcSEcCtD
Scopolamine—Dizziness—Betamethasone—psoriatic arthritis	0.000682	0.0023	CcSEcCtD
Scopolamine—Nausea—Triamcinolone—psoriatic arthritis	0.000675	0.00228	CcSEcCtD
Scopolamine—Nausea—Methylprednisolone—psoriatic arthritis	0.000674	0.00227	CcSEcCtD
Scopolamine—Somnolence—Methotrexate—psoriatic arthritis	0.000667	0.00225	CcSEcCtD
Scopolamine—Vomiting—Dexamethasone—psoriatic arthritis	0.000656	0.00221	CcSEcCtD
Scopolamine—Vomiting—Betamethasone—psoriatic arthritis	0.000656	0.00221	CcSEcCtD
Scopolamine—Rash—Betamethasone—psoriatic arthritis	0.00065	0.00219	CcSEcCtD
Scopolamine—Rash—Dexamethasone—psoriatic arthritis	0.00065	0.00219	CcSEcCtD
Scopolamine—Dermatitis—Betamethasone—psoriatic arthritis	0.00065	0.00219	CcSEcCtD
Scopolamine—Dermatitis—Dexamethasone—psoriatic arthritis	0.00065	0.00219	CcSEcCtD
Scopolamine—Fatigue—Methotrexate—psoriatic arthritis	0.000647	0.00218	CcSEcCtD
Scopolamine—Headache—Betamethasone—psoriatic arthritis	0.000646	0.00218	CcSEcCtD
Scopolamine—Headache—Dexamethasone—psoriatic arthritis	0.000646	0.00218	CcSEcCtD
Scopolamine—Asthenia—Prednisone—psoriatic arthritis	0.000644	0.00217	CcSEcCtD
Scopolamine—Pain—Methotrexate—psoriatic arthritis	0.000642	0.00217	CcSEcCtD
Scopolamine—Pruritus—Prednisone—psoriatic arthritis	0.000635	0.00214	CcSEcCtD
Scopolamine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000619	0.00209	CcSEcCtD
Scopolamine—Nausea—Betamethasone—psoriatic arthritis	0.000613	0.00207	CcSEcCtD
Scopolamine—Nausea—Dexamethasone—psoriatic arthritis	0.000613	0.00207	CcSEcCtD
Scopolamine—Dizziness—Prednisone—psoriatic arthritis	0.000594	0.002	CcSEcCtD
Scopolamine—Body temperature increased—Methotrexate—psoriatic arthritis	0.000593	0.002	CcSEcCtD
Scopolamine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000593	0.002	CcSEcCtD
Scopolamine—Vomiting—Prednisone—psoriatic arthritis	0.000571	0.00193	CcSEcCtD
Scopolamine—Rash—Prednisone—psoriatic arthritis	0.000566	0.00191	CcSEcCtD
Scopolamine—Dermatitis—Prednisone—psoriatic arthritis	0.000566	0.00191	CcSEcCtD
Scopolamine—Headache—Prednisone—psoriatic arthritis	0.000563	0.0019	CcSEcCtD
Scopolamine—Asthenia—Methotrexate—psoriatic arthritis	0.000539	0.00182	CcSEcCtD
Scopolamine—Nausea—Prednisone—psoriatic arthritis	0.000534	0.0018	CcSEcCtD
Scopolamine—Pruritus—Methotrexate—psoriatic arthritis	0.000531	0.00179	CcSEcCtD
Scopolamine—Dizziness—Methotrexate—psoriatic arthritis	0.000496	0.00168	CcSEcCtD
Scopolamine—Vomiting—Methotrexate—psoriatic arthritis	0.000477	0.00161	CcSEcCtD
Scopolamine—Rash—Methotrexate—psoriatic arthritis	0.000473	0.0016	CcSEcCtD
Scopolamine—Dermatitis—Methotrexate—psoriatic arthritis	0.000473	0.0016	CcSEcCtD
Scopolamine—Headache—Methotrexate—psoriatic arthritis	0.00047	0.00159	CcSEcCtD
Scopolamine—Nausea—Methotrexate—psoriatic arthritis	0.000446	0.0015	CcSEcCtD
